MARKER THERAPEUTICS, INC. Debt Conversion, Converted Instrument, Amount
MARKER THERAPEUTICS, INC. (MRKR) reported Debt Conversion, Converted Instrument, Amount of $0 for the 3-month period ending 2015-03-31, per its 10-Q/A filed 2016-04-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2016-04-14
- MARKER THERAPEUTICS, INC. debt conversion, converted instrument, amount for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. debt conversion, converted instrument, amount for the quarter ending 2014-12-31 was $319.00K.
- MARKER THERAPEUTICS, INC. debt conversion, converted instrument, amount for the quarter ending 2014-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. debt conversion, converted instrument, amount for the quarter ending 2014-06-30 was $504.00K.
- MARKER THERAPEUTICS, INC. debt conversion, converted instrument, amount for fiscal 2014 was $4.12M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2015-03-31 | $0.00 10-Q/A · filed 2016-04-14 | $319.00K derived: sum of 2 quarters · filed 2016-04-14 | $319.00K derived: sum of 3 quarters · filed 2016-04-14 | $823.00K derived: sum of 4 quarters · filed 2016-04-14 |
| 2014-12-31 | $319.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2016-04-14 | $319.00K derived: sum of 2 quarters · filed 2016-04-14 | $823.00K derived: sum of 3 quarters · filed 2016-04-14 | $4.12M 10-K · filed 2016-04-14 |
| 2014-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2016-04-14 | $504.00K derived: sum of 2 quarters · filed 2016-04-14 | $3.80M 10-Q/A · filed 2016-04-14 | |
| 2014-06-30 | $504.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-04-14 | $3.80M 10-Q/A · filed 2016-04-14 | ||
| 2014-03-31 | $3.29M 10-Q/A · filed 2016-04-14 | |||
| 2012-06-30 | $254.19K 10-Q/A · filed 2012-09-12 | |||
| 2011-06-30 | $815.53K 10-Q/A · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |